AASLD: American Association for the Study of Liver Diseases
Home | Contact Us | Log In/Out
About Us | Join | Public Policy | Patients | Giving to AASLD | Career Center | News | Worksites | Related Societies
Practice Guidelines
Skip navigation links
Practice Guidelines
Practice Guideline Listing
New/Updated Guidelines
Practice Guidelines Archive
Policies and Disclosures
<asp:ContentPlaceHolder id="PlaceHolderPageTitle" runat="server"/>
 
Practice Guidelines

Practice Guidelines Archive 
|

These evidence-based guidelines are developed and updated regularly by a committee of hepatology experts and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care.

AdobeYou will need Adobe Acrobat Reader to view these documents.


     

 Practice Guidelines Archive
Guideline TopicFilterGuidelineFilter
Hepatitis
June 2007 Inactive2007 February2009
Hepatitis
June 2007 InactiveN/AN/A
Hepatocellular Carcinoma
November 2005 InactiveN/A2010
Acute Liver Failure
May 2005 InactiveAugust 20112011
TIPS
February 2005 InactiveN/A2009
Hepatitis
April 2004 InactiveN/AApril 2009
Ascites
March 2004 InactiveN/AJune 2009
Hepatitis
August 2002 InactiveN/A2010
Fatty Liver Disease
May 2002 InactiveN/AIn progress
Fatty Liver Disease
May 2002 Inactive2002In progress
Hemochromatosis
May 2001 InactiveN/A2010
Hepatic Injury
December 2000 InactiveN/ANone
Cirrhosis
April 2000 InactiveN/AJuly 2009

AASLD strives to review and update its Practice Guidelines every five (5) years, as necessary.  Users are cautioned that in the interim, scientific and medical developments may supercede or invalidate, in whole or in part, specific recommendations in any Guideline. A Guideline is considered to be "inactive" if it has not been updated by AASLD in at least five (5) years, and for this reason particular care must be exercised in placing reliance on an inactive Guideline. 

Guidelines Development

AASLD does not accept corporate support for the development of practice guidelines.  However, AASLD gratefully acknowledges the support of Merck and Bayer HealthCare/Onyx Pharmaceuticals in providing independent medical education grants for PDA software applications for AASLD practice guidelines.